Latest for Canavan Disease
See all trialsThe week in rare diseaseEach date is the day a change was posted. Open an item to see where things stand now.
- Trial statusNo longer enrolling. Early Check: Expanded Screening in Newborns (RTI International)ClinicalTrials.gov
More about Canavan Disease
Patients present in infancy with hypotonia (decreased muscle tone) and developmental delay, typically manifesting by 3-6 months of age with failure to meet developmental milestones. Progressive spasticity develops during the second year of life affecting lower more than upper limbs. Seizures occur in most patients. Visual and hearing loss develop as disease progresses.
Keep reading about Canavan Disease
Most patients become vegetative (profoundly disabled with minimal awareness) by late childhood. MRI characteristically shows white matter changes with a spongy appearance. The severe infantile form presents by 6 months with rapid progression, while rare juvenile variants present later with slower progression but still lead to significant neurological disability.
What are the symptoms of Canavan Disease?
These are common symptoms of Canavan Disease, and how strong they are varies from person to person.
- Developmental delay and hypotonia in infancy
- Loss of developmental milestones
- Spasticity developing in second year of life
- Seizures
- Visual and hearing loss
- Progressive quadriplegia
Who gets Canavan Disease?
Canavan disease typically manifests by age 3-6 months with developmental delay and hypotonia. The condition affects males and females equally. It shows notably higher prevalence in the Ashkenazi Jewish population (approximately 1 in 6,400 to 1 in 13,500) compared to general population (approximately 1 in 100,000), though cases occur across all ethnicities.
Autosomal recessive inheritance means both parents must carry mutations, and approximately 25% of offspring in carrier couples will be affected.
Next steps: find trials you might fitsee what is being testedget help payingget alerts
Which new Canavan Disease medicines are in trials?
Investigational medicines Trial Friend tracks for Canavan Disease, with trial results, safety findings and where each one stands.
How to get help paying for Canavan Disease treatment
Charity funds and drugmaker programs for Canavan Disease, checked at the source.
- From a charity · United Leukodystrophy FoundationHultman Memorial Fund fundOpen
Pays for: Expenses directly related to the affected family member, based on demonstrated hardship (per 12 months), up to $500 per year.
The foundation says: “Applications are reviewed on a rolling basis as funding is available.”
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
Genetic testing for Canavan Disease
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
Finding labs...
Trusted Canavan Disease resources
Reputable organizations and medical references for learning more about Canavan Disease, including disease registries, foundation resources, and clinical guidelines.